Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recurrent synovial chondromatosis of the shoulder treated with osteochondral allograft transplantation.

Created on 26 Aug 2026

Authors

Nain Kamal Aulakh, Cansu Ozdemir, Siddhartha Murhekar, Bijayendra Singh

Published in

BMJ case reports. Volume 19. Issue 8. Aug 25, 2026. Epub Aug 25, 2026.

Abstract

This case concerns synovial chondromatosis, which is an uncommon and benign joint disorder marked by intra-articular cartilaginous nodules. It predominantly affects males, with the knee most involved while shoulder involvement is uncommon. Arthroscopy remains the primary treatment for synovial chondromatosis; however, osteochondral allograft transplantation (OAT) is emerging as a valuable option, particularly in recurrent cases. Because shoulder synovial chondromatosis is rare, evidence regarding long-term outcomes remains limited, making optimal management uncertain.We report a case of a woman in her early 20s with recurrent right shoulder synovial chondromatosis and progressive humeral head erosion following two arthroscopic procedures. This case highlights the role of OAT in structurally compromised glenohumeral joints as arthroscopy alone was insufficient. Follow-up assessments at 1, 3, 12 months and 2 years demonstrated progressive clinical improvement, with the patient achieving near full range of motion by 3 months and full function by 12 months. Imaging at each stage confirmed satisfactory graft integration and healing.

PMID:
42642101
Bibliographic data and abstract were imported from PubMed on 26 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement